Osteocraniostenosis

Osteocraniostenosis, also known as gracile bone dysplasia, is an extremely rare and severe letetal skeletal disorder characterized by gracile (thin and fragile) bones, craniostenosis (premature closure of cranial sutures), and distinctive facial features. The condition primarily affects the skeletal system, with hallmark features including markedly thin long bones with increased susceptibility to fractures, a narrow and elongated skull due to premature fusion of cranial sutures, and microcephaly. Additional features may include thin and beaded ribs, hypoplastic (underdeveloped) clavicles, and decreased mineralization of the calvarium. Affected infants typically present with severe growth restriction and skeletal abnormalities detectable prenatally or at birth. The condition is almost invariably lethal in the perinatal period, with most affected infants being stillborn or dying shortly after birth due to the severity of skeletal and associated abnormalities. The extremely thin and fragile bones distinguish this condition from other skeletal dysplasias. Pulmonary hypoplasia secondary to the thoracic abnormalities may contribute to respiratory failure in affected neonates. Osteocraniostenosis has been associated with heterozygous mutations in the FAM111A gene, which plays a role in DNA replication. Given the lethal nature of this condition, treatment is primarily supportive and palliative. No curative therapy exists. Prenatal diagnosis may be possible through ultrasound identification of characteristic skeletal findings and confirmed by molecular genetic testing. Genetic counseling is recommended for affected families to discuss recurrence risks and reproductive options.

Common questions about Osteocraniostenosis